Sandra L. Rolfs, PA-C Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 600 N Hiatus Rd, Suite 215, Pembroke Pines, FL 33026 Phone: 954-437-3600 Fax: 954-437-8251 |
Mrs. Precy P Kumar, MMS, PA-C Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 600 N Hiatus Rd, Suite 215, Pembroke Pines, FL 33026 Phone: 954-437-3600 Fax: 954-437-8251 |
Dr. Zevy Landman, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 600 N Hiatus Rd, Suite 215, Pembroke Pines, FL 33026 Phone: 954-437-3600 Fax: 954-437-8251 |
News Archive
Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.
Edith Sanford Breast Cancer (ESBC), part of the Sanford Health system based in Sioux Falls, SD, today announced it is partnering with the Athena Breast Health Network, a University of California program, to advance the use of a personalized breast cancer risk assessment.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
The University of Texas MD Anderson Cancer Center and Pfizer will collaborate in the development of immune-based approaches to cancer treatment, the first such agreement made through MD Anderson's Moon Shots Program immunotherapy platform.
› Verified 4 days ago